Dolby Laboratories (DLB) Stock Price, News & Analysis

Company Overview

Dolby Laboratories, Inc. develops audio and imaging technologies for entertainment and communications. The company’s products and intellectual property are used in cinemas, televisions, mobile devices, personal computers, streaming platforms, gaming systems and automobiles to improve sound quality, picture quality and overall viewing experiences.

Dolby’s technology portfolio includes Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and Dolby Digital and Dolby AC-4 audio formats. The company supports the creation, distribution and playback of content, and generates revenue primarily by licensing its technologies to consumer electronics manufacturers, content providers, software developers and other commercial partners.

Founded in 1965 by Ray Dolby, the company initially became known for its noise-reduction systems before expanding into digital audio, cinema sound and advanced imaging technologies. Dolby serves customers and partners globally, with its technologies incorporated into products and services across North America, Europe, Asia and other international markets. Kevin Yeaman serves as Dolby Laboratories’ president and chief executive officer.

Key Stats

• Today's Range: $57.74 to $58.71
• 50-Day Range: $51.69 to $66.27
• 52-Week Range: $48.26 to $72.96
• Volume: 17,535 shs
• Average Volume: 848,937 shs
• Market Capitalization: $5.42 billion
• P/E Ratio: 24.62
• Dividend Yield: 2.49%
• Price Target: $87.50
• Consensus Rating: Moderate Buy

Dolby Laboratories Stock Analysis - MarketRank™

Dolby Laboratories scored higher than 89% of companies evaluated by MarketBeat, and ranked 74th out of 597 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Dolby Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and no sell ratings.

Upside Potential

Dolby Laboratories has a consensus price target of $87.50, representing about 49.5% upside from its current price of $58.51.

Amount of Analyst Coverage

Dolby Laboratories has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 4.02%

Earnings Growth

Earnings for Dolby Laboratories are expected to grow by 4.02% in the coming year, from $3.23 to $3.36 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Dolby Laboratories is 24.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.01.

Price to Earnings Ratio vs. Sector

The P/E ratio of Dolby Laboratories is 24.90, which means that it is trading at a less expensive P/E ratio than the Technology sector average P/E ratio of about 82.11.

Price to Book Value per Share Ratio

Dolby Laboratories has a P/B Ratio of 2.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.51% of the float of Dolby Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Dolby Laboratories has a short interest ratio ("days to cover") of 6.01.

Change versus previous month

Short interest in Dolby Laboratories has recently decreased by 0.02%, indicating that investor sentiment is improving.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Dolby Laboratories pays a meaningful dividend of 2.45%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Dolby Laboratories has been increasing its dividend for 10 years.

Dividend Coverage

The dividend payout ratio of Dolby Laboratories is 61.28%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 42.86% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.04

News Sentiment

Dolby Laboratories has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Technology companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Dolby Laboratories this week, compared to 4 articles on an average week.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Dolby Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,749,388.00 in company stock.

Percentage Held by Insiders

37.93% of the stock of Dolby Laboratories is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.56% of the stock of Dolby Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Record date for 8/19 Dividend: 8/11/2026
• Ex-Dividend for 8/19 Dividend: 8/11/2026
• Dividend Payable: 8/19/2026
• Today: 10/07/2026
• Next Earnings (Estimated): 11/17/2026
• Fiscal Year End: 9/30/2027

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Technology
• Industry: Software
• Sub-Industry: Systems Software
• Current Symbol: NYSE:DLB
• CIK: 1308547
• Web: www.dolby.com
• Phone: (415) 558-0200
• Fax: 415-645-4000
• Employees: 2,051
• Year Founded: 1965

Price Target and Rating

• Average Price Target for Dolby Laboratories: $87.50
• High Price Target: $90.00
• Low Price Target: $85.00
• Potential Upside/Downside: +51.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.35
• Trailing P/E Ratio: 24.66
• Forward P/E Ratio: 17.93
• P/E Growth: N/A
• Net Income: $255.02 million
• Net Margins: 16.70%
• Pretax Margin: 20.44%
• Return on Equity: 11.08%
• Return on Assets: 9.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.19
• Quick Ratio: 3.11

Sales & Book Value

• Annual Sales: $1.35 billion
• Price / Sales: 4.00
• Cash Flow: $4.17 per share
• Price / Cash Flow: 13.90
• Book Value: $27.56 per share
• Price / Book: 2.10

Miscellaneous

• Outstanding Shares: 93,669,000
• Free Float: 58,140,000
• Market Cap: $5.42 billion
• Optionable: Optionable
• Beta: 0.78